71 min listen
Rapid Detection of Bloodborne Pathogens
Rapid Detection of Bloodborne Pathogens
ratings:
Length:
34 minutes
Released:
Sep 19, 2020
Format:
Podcast episode
Description
Sepsis is an infection of the blood. It can be critical and life threatening, and can complicate other co-morbidities. One of the main problems is that a number of bacterial and fungal pathogens can cause a septic state, so physicians are tasked with rapid identification of specific pathogens to render the most appropriate method of care. Unfortunately this usually involves broad treatments with multiple antibiotics and antifungals, as tests to identify discrete pathogens can take days. Dr. Alon Singer is the CEO of Helixbind. They have developed a new technology that allows rapid detection of bloodborne pathogens, eclipsing many of the barriers that previously led to longer detection times and greater patient risk. More information at www.helixbind.com# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Released:
Sep 19, 2020
Format:
Podcast episode
Titles in the series (100)
Success or Failure? Good Study Called Bad, Bad Study Called Gold.: This week’s podcast is an important analysis of two published reports. First, the results from the famous Rothamstead wheat trial show that their transgene does not confer resistance to aphids, inconsistent with their laboratory findings. While this outc by Talking Biotech with Dr. Kevin Folta